Equities
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
SAN:PAR since
announced
Transaction
value
Ocular Therapeutix IncRumoured15 Jan 202615 Jan 2026Rumoured-0.42%--
Dynavax Technologies CorpAnnounced24 Dec 202524 Dec 2025Announced-0.02%1.93bn
Blueprint Medicines CorpDeal completed02 Jun 202502 Jun 2025Deal completed-6.08%9.10bn
Vigil Neuroscience IncDeal completed21 May 202521 May 2025Deal completed-12.10%466.72m
Data delayed at least 15 minutes, as of Feb 10 2026 16:39 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.